Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-Myeloablative Allogeneic Stem Cell Transplant for Metastatic Renal Cell Carcinoma
NCT00262886Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Aug 2001
- Primary completion
- Jul 2007
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic hematopoietic stem cells in renal cell carcinoma (RCC), sponsored by University of Rochester. Started Aug 2001; status: completed.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00262886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262886.